Impact of cross-sensitivity error correction on representative nitrogen-based multiple breath washout data from clinical trials-Reference-Cited by-同舟云学术

Impact of cross-sensitivity error correction on representative nitrogen-based multiple breath washout data from clinical trials

Published:2021-09 Issue: Volume: Page:
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Robinson Paul D.^ORCID,Jensen Renee^ORCID,Seeto Ryan A.,Stanojevic Sanja^ORCID,Saunders Clare^ORCID,Short Christopher^ORCID,Davies Jane C.,Ratjen Felix^ORCID

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Reference19 articles.

1. ERS/ATS Consensus statement for inert gas washout measurement using multiple and single breath tests;Robinson;Eur Respir J,2013

2. Pediatrics ATSAo. Preschool Multiple-Breath Washout Testing. An Official American Thoracic Society Technical Statement;Robinson;Am J Respir Crit Care Med,2018

3. A realistic validation study of a new nitrogen multiple-breath washout system;Singer;PLoS One,2012

4. European Cystic Fibrosis Society Clinical Trial Network Standardisation C. Lung clearance index: evidence for use in clinical trials in cystic fibrosis;Kent;J Cyst Fibros,2014

5. Integrating the multiple breath washout test into international multicentre trials;Saunders;J Cyst Fibros,2020

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or twoF508delalleles;European Respiratory Journal;2024-06-20

2. Impact of Reanalysis of Nitrogen Multiple-Breath Washout on its Relationship with Chest Magnetic Resonance Imaging Findings in Clinically Stable and Pulmonary Exacerbated Children with Cystic Fibrosis;Klinische Pädiatrie;2023-12-18

3. Nationwide lung function monitoring from infancy in newborn-screened children with cystic fibrosis;ERJ Open Research;2023-08-17

4. Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial;Annals of the American Thoracic Society;2023-08

5. How Does the Corrected Exhalyzer Software Change the Predictive Value of LCI in Pulmonary Exacerbations in Children with Cystic Fibrosis?;Diagnostics;2023-07-11